Position in GSK
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$212,458
-$11,227 QoQ
Shares Held
4,053
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#706
of 1,033 holders
Holding Since
Jun 2020
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Atlas Brown,Inc. holds $23,716,828 across 9 Drug Manufacturers - General names. GSK ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
32,094 | $8,150,913 | |
| 2 | ABBV |
AbbVie Inc.
|
30,004 | $7,550,205 | |
| 3 | LLY |
ELI LILLY & Co
|
2,009 | $2,409,654 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,181 | $2,079,258 | |
| 5 | PFE |
Pfizer Inc
|
80,876 | $1,947,493 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
13,373 | $770,551 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,508 | $443,200 | |
| 8 | GSK |
GSK plc
This page
|
4,053 | $212,458 |
All Filings in GSK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $212,458 | 4,053 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $223,685 | 4,053 | Shares | Sole | 2026-04-17 | |
| 2022-06-30 | $248,779 | 5,827 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $248,950 | 5,827 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $252,036 | 5,827 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $218,374 | 5,827 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $227,576 | 5,827 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $203,972 | 5,827 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $211,218 | 5,852 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $289,874 | 7,852 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $235,520 | 5,887 | Shares | Sole | 2020-07-21 | |
| No filing history on record for this holder in this stock. | ||||||